CLASS II Drug recall · Reported 16 Oct 2013 · FDA Enforcement Report

0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj. recalled by Hospira

Hospira is recalling 0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., Single-Dose Vial, distributed nationwide in the US. The recall was initiated on 5 Sep 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 17-400-EV* and 17-401-EV * Note: the lot number may be followed by 01
NDC0409-1159, 0409-1160, 0409-1162, 0409-1163, 0409-1165, 0409-9043
Quantity recalled187,150 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-66295-001
FDA event ID
66295
Recalling firm
Hospira, Lake Forest, IL
Manufacturer
Hospira, Inc.
Classification
Class II
Status
Terminated
Recall initiated
5 Sep 2013
FDA classified
7 Oct 2013
Reported
16 Oct 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

5 Sep 2013Recall initiated by company
7 Oct 2013Classified by FDA+32 days
16 Oct 2013Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility; potential for vial breakage

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 10 mL, Single-Dose Vial, NDC 0409-9045-01, Hospira, Inc., Lake Forest, IL 60045

Where it was distributed

Nationwide and Guam and Abu Dhabi

Nationwide

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility; potential for vial breakage

Which lots are affected?

Lot 17-400-EV* and 17-401-EV * Note: the lot number may be followed by 01

Where was it sold?

Nationwide and Guam and Abu Dhabi

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Hospira

All 225

Other Bupivacaine recalls

All 54